HK1121689A1 - Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids - Google Patents

Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids

Info

Publication number
HK1121689A1
HK1121689A1 HK09101733.1A HK09101733A HK1121689A1 HK 1121689 A1 HK1121689 A1 HK 1121689A1 HK 09101733 A HK09101733 A HK 09101733A HK 1121689 A1 HK1121689 A1 HK 1121689A1
Authority
HK
Hong Kong
Prior art keywords
therapeutically active
active lipids
tissue
producing organ
specific
Prior art date
Application number
HK09101733.1A
Other languages
English (en)
Inventor
Wolfgang Stremmel
Original Assignee
Pat Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pat Gmbh filed Critical Pat Gmbh
Publication of HK1121689A1 publication Critical patent/HK1121689A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK09101733.1A 2005-09-21 2009-02-24 Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids HK1121689A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005045152A DE102005045152A1 (de) 2005-09-21 2005-09-21 Verwendung von therapeutisch wirksamen Lipiden nebst Verfahren zur Herstellung von Organ-/Gewebe-spezifischen therapeutisch wirksamen Lipiden
PCT/DE2006/001651 WO2007033654A1 (fr) 2005-09-21 2006-09-18 Utilisation de lipides a effet therapeutique et procede de fabrication de lipides a effet therapeutique specifiques aux organes/tissus

Publications (1)

Publication Number Publication Date
HK1121689A1 true HK1121689A1 (en) 2009-04-30

Family

ID=37460134

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09101733.1A HK1121689A1 (en) 2005-09-21 2009-02-24 Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids
HK14101049.3A HK1188558A1 (en) 2005-09-21 2014-01-30 Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14101049.3A HK1188558A1 (en) 2005-09-21 2014-01-30 Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids

Country Status (12)

Country Link
US (2) US8883426B2 (fr)
EP (1) EP1926499B9 (fr)
CN (2) CN103432589B (fr)
CY (1) CY1115038T1 (fr)
DE (1) DE102005045152A1 (fr)
DK (1) DK1926499T3 (fr)
ES (1) ES2458304T3 (fr)
HK (2) HK1121689A1 (fr)
PL (1) PL1926499T3 (fr)
PT (1) PT1926499E (fr)
SI (1) SI1926499T1 (fr)
WO (1) WO2007033654A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2923710A1 (fr) * 2014-03-27 2015-09-30 Universitätsklinikum Heidelberg Inhibiteurs de phospholipase bactérienne en tant que modulateurs de la flore bactérienne du côlon
CN110840901A (zh) * 2019-12-12 2020-02-28 南京大学 溶血磷脂酰乙醇胺18:1在制备缓解、治疗炎症性肠病药物中的应用
CN112305120B (zh) * 2020-10-30 2022-02-08 河北医科大学第二医院 代谢物在动脉粥样硬化性脑梗死中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2231547A1 (fr) * 1995-10-11 1997-04-17 Kevin Jon Williams Compositions liposomiques et leurs methodes d'utilisation
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
DK1105141T3 (da) 1998-08-06 2004-03-08 Wolfgang Stremmel Phosphatidylcholin som et medikament med slimhindebeskyttende virkning
US7141552B2 (en) * 2000-01-10 2006-11-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
AU785017B2 (en) * 2000-01-10 2006-08-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
DE10249890A1 (de) * 2002-10-25 2004-05-13 Wieland, Heinrich, Prof. Dr. Gallensäurekonjugate und damit gebildete Partikel

Also Published As

Publication number Publication date
CY1115038T1 (el) 2016-12-14
CN103432589B (zh) 2015-04-29
ES2458304T3 (es) 2014-04-30
WO2007033654A1 (fr) 2007-03-29
PT1926499E (pt) 2014-04-22
EP1926499B9 (fr) 2014-04-16
CN101287499A (zh) 2008-10-15
US20150038472A1 (en) 2015-02-05
HK1188558A1 (en) 2014-05-09
PL1926499T3 (pl) 2014-06-30
DK1926499T3 (da) 2014-04-14
EP1926499B1 (fr) 2014-01-22
DE102005045152A1 (de) 2007-03-22
CN101287499B (zh) 2013-04-03
EP1926499A1 (fr) 2008-06-04
US8883426B2 (en) 2014-11-11
US20080166401A1 (en) 2008-07-10
SI1926499T1 (sl) 2014-05-30
CN103432589A (zh) 2013-12-11

Similar Documents

Publication Publication Date Title
GB2441489B (en) Stylet apparatuses and methods of manufacture
TWI346826B (en) Bonding structure and method of fabricating the same
GB0718972D0 (en) Compounds and methods of making the compounds
IL188730A0 (en) Wound dressing and methods of making and using the same
TWI349334B (en) Dram structure and method of making the same
GB0511883D0 (en) Manufacture of ferroalloys
GB0509845D0 (en) Preparation of therapeutic foam
IL182940A0 (en) Solid electrolyte and method of producing the same
EP2073888A4 (fr) Micro-aiguilles et procédés pour fabriquer des micro-aiguilles
ZA200803555B (en) Manufacture of esters
EP1967171A4 (fr) Timbre transdermique et procede de production de ce timbre
PL2091385T3 (pl) Miotły i sposoby wytwarzania mioteł
EP1967265A4 (fr) Corps à structure en nid d'abeilles et son procédé de production
EP1919477A4 (fr) Procede permettant d'ameliorer l'etat de veille
HK1188558A1 (en) Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids
EP1951357A4 (fr) Batteries de micro-aiguilles et procedes pour leur fabrication
EP1899157A4 (fr) Structures nanometriques et leurs procedes de preparation
GB2423583B (en) Manufacture of interactive surface
EP1870460A4 (fr) Procede pour la production d'une proteine ayant une structure tri-helicoidale
EP1977003A4 (fr) Méthodes et moyens relatifs à des maladies
GB0500700D0 (en) Process for the manufacture of 2-alkyl-3-phenylpropionic acids and alcohols
EP2099437A4 (fr) Construction kératinique poreuse et procédé de fabrication de celle-ci
GB0615295D0 (en) Play structure and accessories therefor
TWM300074U (en) Improved structure of chair chassis
ZA200800590B (en) Method of improving wakefulness

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170918